Patents-Review.com
ClassID:

96773 ⎘

C07K14/02 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; DNA viruses Hepadnaviridae, e.g. hepatitis B virus

Recent Application in this class:
#1
20260098063
2026-04-09

HUMAN PAPILLOMAVIRUS VACCINES AND USES OF THE SAME

 #2
20250230197
2025-07-17

MALARIA VACCINE

 #3
20250223320
2025-07-10

HEPATITIS B VACCINES AND USES OF THE SAME

 #4
20230279057
2023-09-07

Hepatitis B vaccines and uses of the same

 #5
20230241026
2023-08-03

NOVEL DRUG-CONTROLLED SYSTEMS AND USES THEREOF

 #6
20230228736
2023-07-20

IN VITRO HBV CORE PROTEIN ASSAY

 #7
20230211003
2023-07-06

CONJUGATE COMPOUNDS FOR PREVENTING AND/OR TREATING HBV AND/OR HDV INFECTIONS, LIVER DISEASES ANDFOR TARGETING NTCP

 #8
20230083273
2023-03-16

HEPADNAVIRUS CAPSID PROTEIN HETERODIMERS AND VIRUS-LIKE PARTICLES

 #9
20220411475
2022-12-29

HYBRID VIRUS-LIKE PARTICLES AND USE THEREOF AS A THERAPEUTIC HEPATITIS B VACCINE

 #10
20220281924
2022-09-08

ENGINEERED HEPATITIS B CORE POLYPEPTIDE

 #11
20220062234
2022-03-03

Drug-controlled systems and uses thereof

 #12
20220054631
2022-02-24

MHC Class I Associated Hepatitis B Peptides

 #13
20210332089
2021-10-28

Hepatitis B virus replication inhibitor and pharmaceutical composition for treating hepatitis B comprising the same

 #14
20210322544
2021-10-21

VACCINE COMPOSITION COMPRISING HEPATITIS B VIRUS-LIKE PARTICLE AS ADJUVANT

 #15
20210236626
2021-08-05

Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines contaning hepatitis B virus genes

 #16
20210196786
2021-07-01

THERAPY OF ATHEROSCLEROSIS, PRIMARY BILIARY CIRRHOSIS AND NRLP3 INFLAMMASOME-ASSOCIATED DISEASE BY HTCP INHIBITORS

 #17
20210069322
2021-03-11

HEPATITIS B IMMUNISATION REGIMEN AND COMPOSITIONS

 #18
20210024586
2021-01-28

HUMAN PAPILLOMAVIRUS VACCINES AND USES OF THE SAME

 #19
20210015911
2021-01-21

Hepatitis B vaccines and uses of the same

 #20
20200231632
2020-07-23

Engineered hepatitis B core polypeptide

 #21
20200207811
2020-07-02

MALARIA VACCINE

 #22
20190290754
2019-09-26

Vaccine composition comprising hepatitis B virus like particle as adjuvant

 #23
20190271700
2019-09-05

HCV NS4a/modified NS3 polypeptides and uses thereof

 #24
20190216921
2019-07-18

Hepatitis B treatment vaccine on the basis of inactivated, whole recombinant Hansenula polymorpha cells expressing HBsAg

 #25
20190192566
2019-06-27

Non-activated t cells expressing exogenous virus-specific T cell receptor (TCR)

 #26
20190151443
2019-05-23

Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same

 #27
20190083608
2019-03-21

Recombinant Hansenula polymorpha-based high dosage hepatitis B vaccine

 #28
20190083607
2019-03-21

Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines containing hepatitis B virus genes

 #29
20190038740
2019-02-07

MHC class I associated hepatitis B peptides

 #30
20180311339
2018-11-01

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #31
20180296634
2018-10-18

Therapy of atherosclerosis, primary biliary cirrhosis and NRLP3 inflammasome-associated disease by HTCP inhibitors

 #32
20180209958
2018-07-26

Modulation of hepatitis B virus replication

 #33
20180071384
2018-03-15

VACCINES BASED ON HEPATITIS B CORE ANTIGENS

 #34
20170326231
2017-11-16

Epitope of hepatitis B virus surface antigen and binding molecule specifically binding to same for neutralizing hepatitis B virus

 #35
20170000879
2017-01-05

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #36
20160361410
2016-12-15

MHC class I associated peptides for prevention and treatment of hepatitis B virus infection

 #37
20160317652
2016-11-03

Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same

 #38
20160024223
2016-01-28

Treating hepatitis B virus infections by administering receptor associated protein (RAP)

 #39
20150329598
2015-11-19

Stabilized hepatitis B core polypeptides

 #40
20150191509
2015-07-09

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #41
20150110828
2015-04-23

Yeast-based therapeutic for chronic hepatitis B infection

 #42
20140286984
2014-09-25

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #43
20140065182
2014-03-06

Yeast-based therapeutic for chronic hepatitis B infection

 #44
20140023613
2014-01-23

Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same

 #45
20130243805
2013-09-19

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #46
20130236456
2013-09-12

IMMUNOGLOBULIN Fc FRAGMENT TAGGING ACTIVATION OF ENDOGENOUS CD4 AND CD8 T CELLS AND ENHANCEMENT OF ANTITUMOR EFFECTS OF LENTIVECTOR IMMUNIZATION

 #47
20130202554
2013-08-08

COMPOSITIONS AND METHODS THAT ENHANCE AN IMMUNE RESPONSE

 #48
20130171182
2013-07-04

INFLUENZA VACCINE

 #49
20130164289
2013-06-27

HUMAN CYTOMEGALOVIRUS VACCINE

 #50
20120039842
2012-02-16

Compositions and methods that enhance an immune response